Moleculin Biotech, Inc.
MBRX
$7.59
$0.9614.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -358.59% | -18.71% | -241.98% | 81.50% | -135.59% |
| Total Depreciation and Amortization | -21.43% | -9.68% | 0.00% | -3.13% | 3.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,146.77% | 108.37% | 126.53% | -222.16% | 381.74% |
| Change in Net Operating Assets | -405.97% | -147.45% | -32.50% | 98.11% | 226.32% |
| Cash from Operations | -29.40% | -22.30% | 10.21% | 16.85% | -2.76% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.55% | -32.20% | 799,800.00% | -99.98% | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 96.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.55% | -32.20% | 799,800.00% | -99.98% | 18,736.00% |
| Foreign Exchange rate Adjustments | -- | -100.00% | 106.67% | -421.43% | 75.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -437.11% | -104.62% | 167.06% | -256.04% | 75.92% |